These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4891329)

  • 1. "Of trials".
    Isdale IC
    Australas Radiol; 1969 Feb; 13(1):18-22. PubMed ID: 4891329
    [No Abstract]   [Full Text] [Related]  

  • 2. Purpose and methodology in clinical trials on new drugs.
    Collins IS; Thorpe PC
    N Z Med J; 1970 Mar; 71(454):148-51. PubMed ID: 4910417
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality assurance of drugs used in clinical trials: proposal for adapting guidelines.
    Newton PN; Schellenberg D; Ashley EA; Ravinetto R; Green MD; ter Kuile FO; Tabernero P; White NJ; Guerin PJ
    BMJ; 2015 Feb; 350():h602. PubMed ID: 25716700
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological testing for safe O-T-C medications.
    Brogle RC
    Am J Pharm Sci Support Public Health; 1970; 142(1):23-8. PubMed ID: 4935890
    [No Abstract]   [Full Text] [Related]  

  • 5. Current standards in reported drug trials.
    Reiffenstein RJ; Schiltroth AJ; Todd DM
    Can Med Assoc J; 1968 Dec; 99(23):1134-5. PubMed ID: 4881692
    [No Abstract]   [Full Text] [Related]  

  • 6. Pragmatic clinical trials: ethical imperatives and opportunities.
    Kalkman S; van Thiel GJMW; Grobbee DE; van Delden JJM
    Drug Discov Today; 2018 Dec; 23(12):1919-1921. PubMed ID: 29906514
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epidemiology and the pharmaceutical industry].
    Walker AM; García Rodríguez LA; Pérez Gutthann S
    Med Clin (Barc); 1992 Mar; 98(12):465-8. PubMed ID: 1573915
    [No Abstract]   [Full Text] [Related]  

  • 8. Necessary evil?
    Boyce N
    New Sci; 2000 Sep; 167(2554):16-7. PubMed ID: 12549449
    [No Abstract]   [Full Text] [Related]  

  • 9. Measuring Signal Detection Performance: Can We Trust Negative Controls and Do We Need Them?
    Slattery J
    Drug Saf; 2016 May; 39(5):371-3. PubMed ID: 26895343
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial data for all drugs in current use.
    Godlee F
    BMJ; 2012 Oct; 345():e7304. PubMed ID: 23109483
    [No Abstract]   [Full Text] [Related]  

  • 11. Additional requirements for complex interventions.
    Spreckelsen TF; Grant SP; Montgomery P
    BMJ; 2012 Nov; 345():e8003. PubMed ID: 23183069
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug efficacy--double-blind studies.
    Basmajian JV; Adler P; Ord RL
    J Rehabil; 1974; 40(5):26-30. PubMed ID: 4606453
    [No Abstract]   [Full Text] [Related]  

  • 13. John Bell's conflict of interest.
    Baylis MR
    BMJ; 2012 Nov; 345():e7701. PubMed ID: 23150223
    [No Abstract]   [Full Text] [Related]  

  • 14. A revolution in drug approval practices is required.
    Mander A
    BMJ; 2012 Nov; 345():e8002. PubMed ID: 23183068
    [No Abstract]   [Full Text] [Related]  

  • 15. Introducing the HRA's new system.
    Wisely J
    BMJ; 2012 Nov; 345():e8005. PubMed ID: 23183070
    [No Abstract]   [Full Text] [Related]  

  • 16. Paralysed by perfection.
    Gannon F
    EMBO Rep; 2008 May; 9(5):401. PubMed ID: 18451759
    [No Abstract]   [Full Text] [Related]  

  • 17. Committee for Medicinal Products for Human Use (CHMP) guideline on Data Monitoring Committees.
    ; ;
    Stat Med; 2006 May; 25(10):1639-45. PubMed ID: 16639775
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical testing of drugs].
    Begemann H
    Med Klin; 1973 May; 68(18):569-71. PubMed ID: 4576603
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical testing of drugs].
    Elis J
    Cesk Zdrav; 1973; 21(3):126-30. PubMed ID: 4580127
    [No Abstract]   [Full Text] [Related]  

  • 20. Misuse of randomized clinical trials.
    Hofmann F
    Man Med; 1979; 4(2):138-42. PubMed ID: 12083135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.